Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0229 | 1 | 1 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.0032 | 0 | 0.5 |
Onchocerca volvulus | 0.0032 | 0 | 0.5 | |
Toxoplasma gondii | aldose reductase, putative | 0.0032 | 0 | 0.5 |
Loa Loa (eye worm) | oxidoreductase | 0.0032 | 0 | 0.5 |
Onchocerca volvulus | 0.0032 | 0 | 0.5 | |
Onchocerca volvulus | 0.0032 | 0 | 0.5 | |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0229 | 1 | 1 |
Onchocerca volvulus | 0.0032 | 0 | 0.5 | |
Loa Loa (eye worm) | oxidoreductase | 0.0032 | 0 | 0.5 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0229 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0032 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0032 | 0 | 0.5 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0032 | 0 | 0.5 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0032 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0229 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0032 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0032 | 0 | 0.5 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0229 | 1 | 1 |
Onchocerca volvulus | 0.0032 | 0 | 0.5 | |
Onchocerca volvulus | 0.0032 | 0 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0229 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0032 | 0 | 0.5 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0229 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0229 | 1 | 1 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0229 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0229 | 1 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0229 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0032 | 0 | 0.5 |
Giardia lamblia | Rrm3p helicase | 0.0229 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0032 | 0 | 0.5 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0229 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 132 uM | Antiproliferative activity against human HT29 cells | ChEMBL. | 18023585 |
GI50 (functional) | = 132 uM | Antiproliferative activity against human HT29 cells | ChEMBL. | 18023585 |
IC50 (functional) | = 43 uM | Dose required to inhibit cell growth was determined against L1210 cell line of murine lymphocytotic leukemia | ChEMBL. | 11262080 |
IC50 (functional) | = 43 uM | Dose required to inhibit cell growth was determined against L1210 cell line of murine lymphocytotic leukemia | ChEMBL. | 11262080 |
IC50 (functional) | = 101 uM | Dose required to inhibit cell growth was determined against K562 cell line of chronic myelogenous leukemia | ChEMBL. | 11262080 |
IC50 (functional) | = 101 uM | Dose required to inhibit cell growth was determined against K562 cell line of chronic myelogenous leukemia | ChEMBL. | 11262080 |
IC50 (functional) | = 132 uM | Dose required to inhibit cell growth was determined against HT-29 cell line of human adenocarcinoma | ChEMBL. | 11262080 |
IC50 (functional) | = 132 uM | Dose required to inhibit cell growth was determined against HT-29 cell line of human adenocarcinoma | ChEMBL. | 11262080 |
NA (functional) | 0 | Dose required to inhibit cell growth was determined against MDA-MB231 cell line of human non-hormone dependent breast carcinoma ; Not active represents IC50 >400 uM | ChEMBL. | 11262080 |
NA (functional) | 0 | Dose required to inhibit cell growth was determined against CHO cell line; Not active represents IC50 >400 uM | ChEMBL. | 11262080 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.